Ecstasy-for-Medicine Advocate Looks for Cash Lifeline

MAPS, a nonprofit, is working on an $85 million private share sale to keep itself afloat until mid-2024, when it hopes to start selling MDMA in the U.S.

from WSJ.com: World News https://ift.tt/DuYiTAN
via IFTTT

Comments

Popular posts from this blog

Future Demand on Photodynamic Therapy Industry 2023 to 2032, By Industry Overview, Opportunities, In-Depth Analysis with Top Key Players

Global Polycarbonate (PC) Resin Market Research 2023 by Future Trend, Growth rate, Opportunity,Industry Analysis 2033